The purpose of this study is to assess Mixhers HERTIME supplements efficacy in alleviating menstrual cycle symptoms.
All participants, after providing written informed consent, will drink a daily self-administered powder-mix supplement in water of either placebo or Mixhers HERTIME for 120 consecutive days. Surveys will be administered electronically to each participant in the first month to assess baseline menstrual cycle symptoms. In addition, before starting the supplement, participants will take the electronic survey "The Premenstrual Symptoms Screening Tool". During the first month of taking the supplement, participants will take an allergy and constitutional symptom survey electronically to assess for any adverse reactions to the product. Each month for four months, participants will complete an electronic survey assessing menstrual cycle symptoms after a menstrual cycle is completed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
100
A daily self-administered powder supplement packet mixed into water.
A daily self-administered powder placebo supplement packet mixed into water.
Midwestern University
Glendale, Arizona, United States
Menstrual Cramping and/or Back Pain
Measured through post-menstrual bleeding electronic survey 1-10 severity scale
Time frame: 120 days
Mood Regulation
Measured through post-menstrual bleeding electronic survey 1-10 mood scale
Time frame: 120 days
Bloating
Measured through post-menstrual bleeding electronic survey 1-10 severity scale
Time frame: 120 days
Menstrual Bleeding Volume
Measured through post-menstrual bleeding electronic survey 1-10 scale of flow volume
Time frame: 120 days
Menstrual Bleeding Duration
Measured through post-menstrual bleeding electronic survey recording start and end day of menstrual bleeding
Time frame: 120 days
Fatigue
Measured through post-menstrual bleeding electronic survey 1-10 scale of fatigue experienced
Time frame: 120 days
Acne
Measured through post-menstrual bleeding electronic survey 1-10 severity scale
Time frame: 120 days
Difficulty Concentrating
Measured through post-menstrual bleeding electronic survey 1-10 severity scale
Time frame: 120 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Overeating/Food Cravings
Measured through post-menstrual bleeding electronic survey 1-10 severity scale
Time frame: 120 days
Insomnia
Measured through post-menstrual bleeding electronic survey 1-10 severity scale
Time frame: 120 days
Hypersomnia
Measured through post-menstrual bleeding electronic survey 1-10 severity scale
Time frame: 120 days
Period symptom interference with school/work efficiency/productivity
Measured through post-menstrual bleeding electronic survey four-point Likert scale
Time frame: 120 days
Period symptom interference with social life activities
Measured through post-menstrual bleeding electronic survey four-point Likert scale
Time frame: 120 days
Period symptom interference with physical activity (sports, gym, or daily performance)
Measured through post-menstrual bleeding electronic survey four-point Likert scale
Time frame: 120 days
Any positive or negative mood changes noticed during period
Measured through post-menstrual bleeding electronic survey free response prompt
Time frame: 120 days
Any positive or negative mood changes noticed during other weeks of the menstrual cycle not bleeding
Measured through post-menstrual bleeding electronic survey free response prompt
Time frame: 120 days
Non-steroidal anti-inflammatory drug use for acute symptoms during menstrual bleeding
Measured through post-menstrual bleeding electronic survey free response prompt
Time frame: 120 days
Number of pads/tampons/other products used during menstrual bleeding
Measured through post-menstrual bleeding electronic survey free response prompt
Time frame: 120 days